A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Clinical trial NCT02315534 · COMPLETED
Trial details
- NCT number
- NCT02315534
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2018-10-09
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.